Supreme Court of the United States · Official docket →
GlaxoSmithKline, LLC, et al. v. Superior Court of California, Alameda County
Paid petition · Court of Appeal of California, First Appellate District, No. A166778 · judgment October 23, 2023
Before the decision, roughly the 4.1% base rate. The model weighted this up for counsel with five or more prior petitions here, a dissent in the court below (flagged in the petition), and a business petitioner.
Question presented
Andrew T. Bayman Matthew J. Blaschke KING & SPALDING LLP Rachel S. Rubens 1180 Peachtree Street, KING & SPALDING LLP Suite 1600 50 California Street, Atlanta, GA 30309 Suite 3300 Telephone: (404) 572-4600 San Francisco, CA 94111 Facsimile: (404) 572-5100 Telephone: (415) 318-1212 abayman@kslaw.com Facsimile: (415) 318-1300 mblaschke@kslaw.com rrubens@kslaw.com Counsel for Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation Joseph G. Petrosinelli Amy Mason Saharia Jessica B. Rydstrom WILLIAMS & CONNOLLY LLP 680 Maine Avenue, SW Washington, DC 20024 Telephone: (202) 434-5000 Facsimile: (202) 434-5029 jpetrosinelli@wc.com asaharia@wc.com jrydstrom@wc.com Counsel for Pfizer, Inc.
Counsel of record
For petitioner
Jay Philip Lefkowitz
Kirkland & Ellis LLP
For respondent
—
Proceedings
- Oct 07 2024Petition DENIED.
- Aug 07 2024DISTRIBUTED for Conference of 9/30/2024.
- Jul 18 2024Brief amicus curiae of The Chamber of Commerce of the United States of America filed.
- Jun 14 2024Petition for a writ of certiorari filed. (Response due July 18, 2024)
- Mar 13 2024Application (23A836) granted by Justice Kagan extending the time to file until June 15, 2024.
- Mar 08 2024Application (23A836) to extend the time to file a petition for a writ of certiorari from April 16, 2024 to June 15, 2024, submitted to Justice Kagan.